210. Neutropenia and Associated Infectious Complications Among Kidney Transplant Recipients Receiving Valganciclovir Prophylaxis in the United States: An Administrative Claims Database Study

BACKGROUND: Valganciclovir (VGCV) prophylaxis is commonly utilized to prevent cytomegalovirus (CMV) infection among high (D+/R-) and intermediate (R+) risk kidney transplant recipients (KTRs). Due to the myelosuppressive effects of VGCV, KTRs may be at an increased risk of opportunistic infections (...

Descripción completa

Detalles Bibliográficos
Autores principales: Turzhitsky, Vladimir, Raval, Amit D, Moise, Pamela, Merchant, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752229/
http://dx.doi.org/10.1093/ofid/ofac492.287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752229/
http://dx.doi.org/10.1093/ofid/ofac492.287

Ejemplares similares